Search research articles
Contact Us
Filters
Showing results (211-220 of 254) with videos related to
Page
of 26
Sort By:
The Journal of Infectious Diseases
|
March 23, 2026
Establishment of a Neonatal Natural Transmission Model for CMV Vaccine Development
Teeba Jihad, Xiaoyuan S Chi, Zhiqing He, et al.
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America
|
May 1, 2023
Efficacy of a 4-Antigen Staphylococcus aureus Vaccine in Spinal Surgery: The STaphylococcus aureus suRgical Inpatient Vaccine Efficacy (STRIVE) Randomized Clinical Trial
Hamid Hassanzadeh, James Baber, Elizabeth Begier, et al.
The Journal of Infectious Diseases
|
April 12, 2022
Horizontal Transmission of Cytomegalovirus in a Rhesus Model Despite High-Level, Vaccine-Elicited Neutralizing Antibody and T-Cell Responses
Julia Li, Sabine Wellnitz, Xiaoyuan S Chi, et al.
Vaccine
|
November 8, 2005
A recombinant 63-kDa form of Bacillus anthracis protective antigen produced in the yeast Saccharomyces cerevisiae provides protection in rabbit and primate inhalational challenge models of anthrax infection
Robert W Hepler, Rosemarie Kelly, Tessie B McNeely, et al.
Vaccine
|
February 10, 2009
Detection of LP2086 on the cell surface of Neisseria meningitidis and its accessibility in the presence of serogroup B capsular polysaccharide
Lisa K McNeil, Ellen Murphy, Xiao-Juan Zhao, et al.
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America
|
August 24, 2024
CLOVER (CLOstridium difficile Vaccine Efficacy tRial) Study: A Phase 3, Randomized Trial Investigating the Efficacy and Safety of a Detoxified Toxin A/B Vaccine in Adults 50 Years and Older at Increased Risk of Clostridioides difficile Infection
Curtis J Donskey, Erik R Dubberke, Nicola P Klein, et al.
Carbohydrate Research
|
April 12, 2003
Isolation, structural characterization, and immunological evaluation of a high-molecular-weight exopolysaccharide from Staphylococcus aureus
Joseph G Joyce, Chitrananda Abeygunawardana, Qiuwei Xu, et al.
Journal of the Pediatric Infectious Diseases Society
|
March 17, 2023
Immunogenicity and Safety of a Third COVID-19 BNT162b2 mRNA Vaccine Dose in 5- to 11-Year Olds
Eric A F Simões, Nicola P Klein, Charu Sabharwal, et al.
The Pediatric Infectious Disease Journal
|
May 23, 2013
A multi-country evaluation of Neisseria meningitidis serogroup B factor H-binding proteins and implications for vaccine coverage in different age groups
Susan K Hoiseth, Ellen Murphy, Lubomira Andrew, et al.
Plos One
|
January 15, 2019
Molecular epidemiology and expression of capsular polysaccharides in Staphylococcus aureus clinical isolates in the United States
Naglaa Mohamed, Yekaterina Timofeyeva, Dorota Jamrozy, et al.
Page
of 26
Search research articles
Search
Showing results (211-220 of 254) with videos related to
Sort By:
Page
of 26
The Journal of Infectious Diseases
|
March 23, 2026
Establishment of a Neonatal Natural Transmission Model for CMV Vaccine Development
Teeba Jihad, Xiaoyuan S Chi, Zhiqing He, et al.
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America
|
May 1, 2023
Efficacy of a 4-Antigen Staphylococcus aureus Vaccine in Spinal Surgery: The STaphylococcus aureus suRgical Inpatient Vaccine Efficacy (STRIVE) Randomized Clinical Trial
Hamid Hassanzadeh, James Baber, Elizabeth Begier, et al.
The Journal of Infectious Diseases
|
April 12, 2022
Horizontal Transmission of Cytomegalovirus in a Rhesus Model Despite High-Level, Vaccine-Elicited Neutralizing Antibody and T-Cell Responses
Julia Li, Sabine Wellnitz, Xiaoyuan S Chi, et al.
Vaccine
|
November 8, 2005
A recombinant 63-kDa form of Bacillus anthracis protective antigen produced in the yeast Saccharomyces cerevisiae provides protection in rabbit and primate inhalational challenge models of anthrax infection
Robert W Hepler, Rosemarie Kelly, Tessie B McNeely, et al.
Vaccine
|
February 10, 2009
Detection of LP2086 on the cell surface of Neisseria meningitidis and its accessibility in the presence of serogroup B capsular polysaccharide
Lisa K McNeil, Ellen Murphy, Xiao-Juan Zhao, et al.
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America
|
August 24, 2024
CLOVER (CLOstridium difficile Vaccine Efficacy tRial) Study: A Phase 3, Randomized Trial Investigating the Efficacy and Safety of a Detoxified Toxin A/B Vaccine in Adults 50 Years and Older at Increased Risk of Clostridioides difficile Infection
Curtis J Donskey, Erik R Dubberke, Nicola P Klein, et al.
Carbohydrate Research
|
April 12, 2003
Isolation, structural characterization, and immunological evaluation of a high-molecular-weight exopolysaccharide from Staphylococcus aureus
Joseph G Joyce, Chitrananda Abeygunawardana, Qiuwei Xu, et al.
Journal of the Pediatric Infectious Diseases Society
|
March 17, 2023
Immunogenicity and Safety of a Third COVID-19 BNT162b2 mRNA Vaccine Dose in 5- to 11-Year Olds
Eric A F Simões, Nicola P Klein, Charu Sabharwal, et al.
The Pediatric Infectious Disease Journal
|
May 23, 2013
A multi-country evaluation of Neisseria meningitidis serogroup B factor H-binding proteins and implications for vaccine coverage in different age groups
Susan K Hoiseth, Ellen Murphy, Lubomira Andrew, et al.
Plos One
|
January 15, 2019
Molecular epidemiology and expression of capsular polysaccharides in Staphylococcus aureus clinical isolates in the United States
Naglaa Mohamed, Yekaterina Timofeyeva, Dorota Jamrozy, et al.
Page
of 26